Jeltsch M.
From molecular biology to a causal treatment of lymphatic system disorders [Internet]. 38. Jahreskongress der Deutschen Gesellschaft für Lymphologie e. V. Halle (Saale), Germany: Deutsche Gesellschaft für Lymphologie; 2014.
https://jeltsch.org/abstract-Halle2014 Jussila L, Veikkola T, Jeltsch M, Thurston G, McDonald D, Achen M, et al..
Signalling via VEGFR-3 is sufficient for lymphangiogenesis in transgenic mice. In Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications. Miami Beach, Florida; 2001.
Jussila et al., 2001 (279.47 KB)